bortezomib

The medicine is used to treat multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in adults.

Form: powder for preparation of injection solution

ATC: L01XG01

Manufacturer: Adamed Pharma S.A. Oncotec Pharma Produktion GmbH Tecnimede - Sociedade Tecnico-Medicinal S.A.

The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and in the treatment of mantle cell lymphoma (a type of cancer affecting the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Adamed Pharma S.A., Synhon s.r.o., Synthon Hispania S.L.

The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes) in individuals at least 18 years old.

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Adamed Pharma S.A. Synthon Hispania S.L. Synthon s.r.o.

The medicine is used to treat multiple myeloma (a type of bone marrow cancer) in adults and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Adamed Pharma S.A. Synthon Hispania S.L. Synthon s.r.o.

The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XG01

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.

The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer affecting the lymph nodes).

Form: solution for injection

ATC: L01XG01

Manufacturer: EVER Pharma Jena GmbH

The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and in the treatment of mantle cell lymphoma (a type of lymph node cancer).

Form: powder for preparation of injection solution

ATC: L01XG01

Manufacturer: Synthon Hispania S.L. Synthon s.r.o.

The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a type of lymph node cancer) in patients over 18 years of age.

Form: powder for preparation of injection solution

ATC: L01XG01

Manufacturer: Synthon Hispania S.L. Synthon s.r.o.

This medicine is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Krka, d.d., Novo mesto

The medicine is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma in adults over 18 years of age.

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Krka, d.d., Novo mesto

The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Synthon Hispania S.L. Synthon s.r.o.

The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Synthon Hispania S.L. Synthon s.r.o.

The medicine is used in the treatment of multiple myeloma (a bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Pharmadox Healthcare Ltd.

The medicine is used in adult patients for the treatment of multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Betapharm Arzneimittel GmbH Rual Laboratories SRL

The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XG01

Manufacturer: PHARMIDEA SIA

The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Synthon Hispania S.L. Synthon s.r.o.

The medicine is used in patients over 18 years of age for the treatment of multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a type of cancer affecting the lymph nodes).

Form: powder for preparation of injection solution

ATC: L01XX32

Manufacturer: Synthon Hispania S.L. Synthon s.r.o.